Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

NCT02242344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Placebo

Sponsor

Boehringer Ingelheim